FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316079116> ?p ?o ?g. }

• W4316079116 endingPage "e1150" @default.
• W4316079116 startingPage "e1149" @default.
• W4316079116 abstract "Introduction: There are a number of reports that raise safety concerns on the association between proton pump inhibitors (PPIs) and the risk of gastric cancer both overall as well as isolated gastric cardia. Methods: We performed an updated systematic review and meta-analysis of observational studies published through January 2022 that examined the association between > 6 months PPI use and the risk of gastric cancer overall and gastric cardia cancer specifically. The inclusion criteria were classification as either a case-control or cohort study, participants 18 years or older, long-term ( > 6 months) PPI use, and gastric cancer as a specified outcome. Excluded studies were case reports, interventional studies, conducted in the pediatric population and used animal models. Study quality was evaluated using the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. Pooled adjusted risk estimates were calculated using random effects model, and heterogeneity among studies was examined as I2 statistic. Results: We identified 15 publications with 16 studies fulfilling inclusion and exclusion criteria: 6 reported nested case-control studies, 1 case-control, 1 prospective cohort, 6 retrospective cohort, and 1 paper with both case-control and prospective cohort studies. Only 8 studies accounted for Helicobacter pylori. Most studies (5 of 8) that examined gastric cardia risks reported no significant association. Pooled unadjusted odds ratios from case control studies were 1.73 (95% CI: 1.43, 1.85) from the 5 overall gastric studies, and 1.26 (95% CI: 0.58, 2.72) from the 6 gastric cardia studies. Most (12 of 15) reported a statistically significant adjusted risk estimate of the association of PPI usage and overall gastric cancer risk, and 3 studies reported no association. Pooled unadjusted risk ratios from cohort studies were 2.57 (95% CI: 2.01, 3.28) from the 8 overall gastric cancer studies, and 1.61 (95% CI: 0.93-2.78) from the 3 gastric cardia studies. The I2 ranged between 23 and 88%. Most (15 of 16) had at least moderate risk of bias on the ROBINS-I tool with 1 study with a serious risk of bias (Table). Conclusion: Observational studies show inconsistent and mostly non-significant (individual or pooled) association between PPI and gastric cardia. For overall gastric, pooled results show a modest statistical association, but considerable heterogeneity among studies, study design limitations and at least moderate risk of bias do not support an etiological relationship between PPI and gastric cancer. Table 1. - Fifteen observational studies that examined the association between PPIs and risk of gastric cancer (GC) Paper (Year of Publication) Area Study design Gastric cancer (GC) site Patient source Adjusted risk estimate (95% CI) ROBINS-I Score Garcia Rodriguez et. al (2006) United Kingdom Nested case-control Overall (any gastric site)Gastric cardia General Practitioners Research Database Adjusted OR for Cardia: 1.06 (CI 0.57-2.00) Moderate risk Duan et. al (2008) United States Case-control Overall (any gastric site)Gastric cardia University of Southern California Cancer Surveillance Program Adjusted OR for Cardia with PPI use for < 1year: 0.65 (0.31-1.37)1-3 years: 0.70 (CI 0.32-1.49)> 3 years: 1.29 (CI 0.70-2.36) Moderate risk Tamim et. al (2008) Canada Nested case-control Overall (any gastric site)Gastric cardia Quebec health insurance plan databases Adjusted OR for overall GC: 1.46 (CI 1.22-1.74)Cardia: 0.58 (CI 0.26-1.32) Moderate risk Poulsen et. al (2009) Denmark Prospective cohort Overall (any gastric site) Danish Civil Registration System Adjusted IRR for overall GC: 1.2 (CI 0.8-2.0) Moderate risk Wennerstrom et. al (2017) Netherlands Nested case-control Overall (any gastric site)Gastric cardia Danish Civil Registration System Adjusted HR for Cardia: 2.51 (CI 2.26-2.79) Moderate risk Brusselaers et. al (2017) Sweden Retrospective cohort Overall (any gastric site)Gastric cardia The Swedish Cancer Registry Adjusted SIR for overall GC: 3.38 (CI 3.25-3.53)Cardia: 3.55 (CI 3.27-3.86) Moderate risk Lai et. al (2018) Taiwan Case-control Overall (any gastric site) Taiwan National Health Insurance Program Adjusted OR for overall GC: 2.00 (CI 1.36-2.95) Moderate risk Peng et. al (2018) Taiwan Nested case-control Overall (any gastric site)Gastric cardia National Health Insurance Research Database; Registry of Catastrophic Illness Adjusted OR for overall GC: 2.48 (CI 1.38-4.38)Cardia: 2.58 (CI 1.38-4.83) Moderate risk Cheung et. al (2018) Hong Kong Retrospective cohort Overall (any gastric site)Gastric cardia Clinical Data Analysis and Reporting System of Hong Kong Hospital Authority Adjusted HR for overall GC: 2.19 (CI 1.31-3.66)Cardia: 1.24 (CI 0.35-4.34) Moderate risk Niikura et. al (2018) Japan Retrospective cohort Overall (any gastric site) University Tokyo Hospital database Adjusted HR for overall GC: 3.61 (CI 1.49-8.77) Serious risk Brusselaers et. al (2019) Sweden Retrospective cohort Overall (any gastric site) The Swedish Cancer Registry Adjusted SIR for overall GC: 2.97 (CI 2.83-3.10) Moderate risk Lee et. al (2020) United States Nested case-control Overall (any gastric site)Gastric cardia Kaiser Permanente Northern California Adjusted OR for overall GC: 1.07 (CI 0.81-1.42)Cardia: 0.98 (CI 0.68-1.40) Moderate risk Liu et. al (2020) United Kingdom Nested case-control Overall (any gastric site) Primary Care Clinical Information Unit Adjusted OR for overall 1.49 (CI 1.24-1.80) Moderate risk Liu et. al (2020) United Kingdom Prospective cohort Overall (any gastric site) UK BioBank Adjusted HR for overall GC: 1.28 (CI 0.86-1.90)Cardia: 0.81 (CI 0.40-1.64) Moderate risk Ng et. al (2021) Hong Kong Retrospective cohort Overall (any gastric site) PCI Registry and Clinical Data and Analysis Reporting System Adjusted HR for overall GC: 2.06 (CI 1.01-4.18) Low risk Seo et. al (2021) South Korea Retrospective cohort Overall (any gastric site) National Health Insurance Service-National Sample Cohort (old version); Observational Medical Outcomes Partnership-Common Data Model Adjusted HR for overall GC: 2.37 (CI 1.56-3.68) Moderate risk" @default.
• W4316079116 created "2023-01-14" @default.
• W4316079116 creator A5029019643 @default.
• W4316079116 creator A5032435720 @default.
• W4316079116 creator A5035678916 @default.
• W4316079116 creator A5054632720 @default.
• W4316079116 date "2022-10-01" @default.
• W4316079116 modified "2023-10-14" @default.
• W4316079116 title "S1608 The Risk of Gastric Cancer (Overall and Cardia Only) With the Use of Proton Pump Inhibitors in Observational Studies: A Systematic Review and Meta-Analysis" @default.
• W4316079116 doi "https://doi.org/10.14309/01.ajg.0000863072.72710.b4" @default.
• W4316079116 hasPublicationYear "2022" @default.
• W4316079116 type Work @default.
• W4316079116 citedByCount "0" @default.
• W4316079116 crossrefType "journal-article" @default.
• W4316079116 hasAuthorship W4316079116A5029019643 @default.
• W4316079116 hasAuthorship W4316079116A5032435720 @default.
• W4316079116 hasAuthorship W4316079116A5035678916 @default.
• W4316079116 hasAuthorship W4316079116A5054632720 @default.
• W4316079116 hasBestOaLocation W43160791161 @default.
• W4316079116 hasConcept C121608353 @default.
• W4316079116 hasConcept C126322002 @default.
• W4316079116 hasConcept C156957248 @default.
• W4316079116 hasConcept C188816634 @default.
• W4316079116 hasConcept C201903717 @default.
• W4316079116 hasConcept C23131810 @default.
• W4316079116 hasConcept C2908647359 @default.
• W4316079116 hasConcept C71924100 @default.
• W4316079116 hasConcept C72563966 @default.
• W4316079116 hasConcept C95190672 @default.
• W4316079116 hasConcept C99454951 @default.
• W4316079116 hasConceptScore W4316079116C121608353 @default.
• W4316079116 hasConceptScore W4316079116C126322002 @default.
• W4316079116 hasConceptScore W4316079116C156957248 @default.
• W4316079116 hasConceptScore W4316079116C188816634 @default.
• W4316079116 hasConceptScore W4316079116C201903717 @default.
• W4316079116 hasConceptScore W4316079116C23131810 @default.
• W4316079116 hasConceptScore W4316079116C2908647359 @default.
• W4316079116 hasConceptScore W4316079116C71924100 @default.
• W4316079116 hasConceptScore W4316079116C72563966 @default.
• W4316079116 hasConceptScore W4316079116C95190672 @default.
• W4316079116 hasConceptScore W4316079116C99454951 @default.
• W4316079116 hasIssue "10S" @default.
• W4316079116 hasLocation W43160791161 @default.
• W4316079116 hasLocation W43160791162 @default.
• W4316079116 hasOpenAccess W4316079116 @default.
• W4316079116 hasPrimaryLocation W43160791161 @default.
• W4316079116 hasRelatedWork W1999831006 @default.
• W4316079116 hasRelatedWork W2128797028 @default.
• W4316079116 hasRelatedWork W2527975648 @default.
• W4316079116 hasRelatedWork W2751522350 @default.
• W4316079116 hasRelatedWork W3094705713 @default.
• W4316079116 hasRelatedWork W3127319258 @default.
• W4316079116 hasRelatedWork W3180723636 @default.
• W4316079116 hasRelatedWork W4241056401 @default.
• W4316079116 hasRelatedWork W4308490732 @default.
• W4316079116 hasRelatedWork W4321793016 @default.
• W4316079116 hasVolume "117" @default.
• W4316079116 isParatext "false" @default.
• W4316079116 isRetracted "false" @default.
• W4316079116 workType "article" @default.